Abstract
Background:
The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.
Methods:
A cohort of 38,117 symptomatic patients aged 18–49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.
Results:
Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5–96.7%), specificity was 88.5% (88.2–88.8%), positive predictive value (PPV) was 2.2% (1.8–2.6%), and negative predictive value was 100% (100–100%). PPVs decreased in younger age groups (18–29, 30–39, 40–49 years).
Conclusions:
FIT performs excellently for patients aged 40–49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.
The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.
Methods:
A cohort of 38,117 symptomatic patients aged 18–49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.
Results:
Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5–96.7%), specificity was 88.5% (88.2–88.8%), positive predictive value (PPV) was 2.2% (1.8–2.6%), and negative predictive value was 100% (100–100%). PPVs decreased in younger age groups (18–29, 30–39, 40–49 years).
Conclusions:
FIT performs excellently for patients aged 40–49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.
| Original language | English |
|---|---|
| Pages (from-to) | 1170-1177 |
| Number of pages | 8 |
| Journal | British Journal of Cancer |
| Volume | 133 |
| Issue number | 8 |
| Early online date | 22 Aug 2025 |
| DOIs | |
| Publication status | Published - 2 Nov 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2025.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The diagnostic accuracy of the faecal immunochemical test for the detection of early-onset colorectal cancer: an age-stratified analysis in South West England'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver